The hemozoin conundrum: Is malaria pigment immune-activating, inhibiting, or simply a bystander?

Trends in Parasitology

Volumn 29, Issue 10, 2013, Pages 469-476

  Boura, Márcia ^a   Frita, Rosangela ^a   Góis, Ana ^a   Carvalho, Tânia ^a   Hänscheid, Thomas ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Hemozoin; Immune modulation; Persistence in tissues; Phagocytosis

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; HEME; HEMOZOIN; PIGMENT;

BIOLOGICAL ACTIVITY; CELL DAMAGE; DRUG TARGETING; ERYTHROCYTE; GRANULOCYTE; HISTOPATHOLOGY; IN VITRO STUDY; MALARIA; MONOCYTE; NONHUMAN; PARASITE CULTIVATION; PHAGOCYTOSIS; PLASMODIUM FALCIPARUM; REVIEW;

EID: 84884404504     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2013.07.005     Document Type: Review

References (67)

1. Hempelmann E., Egan T.J. Pigment biocrystallization in Plasmodium falciparum. Trends Parasitol. 2002, 18:11.
2. Kapishnikov S., et al. Oriented nucleation of hemozoin at the digestive vacuole membrane in Plasmodium falciparum. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:11188-11193.
3. Pisciotta J.M., et al. The role of neutral lipid nanospheres in Plasmodium falciparum haem crystallization. Biochem. J. 2007, 402:197-204.
4. Hoang A.N., et al. Crystallization of synthetic haemozoin (β-haematin) nucleated at the surface of lipid particles. Dalton Trans. 2011, 39:1235-1244.
5. Jani D., et al. HDP - a novel heme detoxification protein from the malaria parasite. PLoS Pathog. 2008, 4:e1000053.
6. Omodeo-Salè F., et al. Destabilisation and subsequent lysis of human erythrocytes induced by Plasmodium falciparum haem products. Eur. J. Haematol. 2005, 74:324-332.
7. Weissbuch I., Leiserowitz L. Interplay between malaria, crystalline hemozoin formation, and antimalarial drug action and design. Chem. Rev. 2008, 108:4899-4914.
8. Shio M.T., et al. Innate inflammatory response to the malarial pigment hemozoin. Microbes Infect. 2010, 12:889-899.
9. Egan T.J., et al. Characterisation of synthetic β-haematin and effects of the antimalarial drugs quinidine, halofantrine, desbutylhalofantrine and mefloquine on its formation. J. Inorg. Biochem. 1999, 73:101-107.
10. Hänscheid T., et al. Haemozoin: from melatonin pigment to drug target, diagnostic tool, and immune modulator. Lancet Infect. Dis. 2007, 7:675-685.
11. Tekwani B.L., Walker L. Targeting the hemozoin synthesis pathway for new antimalarial drug discovery: technologies for in vitro β-hematin formation assay. Comb. Chem. High Throughput Screen. 2005, 8:63-79.
12. Loup C., et al. Trioxaquines and heme-artemisinin adducts inhibit the in vitro formation of hemozoin better than chloroquine. Antimicrob. Agents Chemother. 2007, 51:3768-3770.
13. Chugh M., et al. Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:5392-5397.
14. Muñoz-Durango K., et al. Detection, characterization, and screening of heme-binding molecules by mass spectrometry for malaria drug discovery. Anal. Chem. 2012, 84:3324-3329.
15. Hänscheid T., et al. Automated malaria diagnosis using pigment detection. Parasitol. Today 2000, 16:549-551.
16. Mens P.F., et al. Laboratory evaluation on the sensitivity and specificity of a novel and rapid detection method for malaria diagnosis based on magneto-optical technology (MOT). Malar. J. 2010, 9:207.
17. Lyke K.E., et al. Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria. Am. J. Trop. Med. Hyg. 2005, 69:253-259.
18. Nguyen P.H., et al. Intraleucocytic malaria pigment and prognosis in severe malaria. Trans. R. Soc. Trop. Med. Hyg. 1995, 89:200-204.
19. Hänscheid T., et al. Full blood count and haemozoin-containing leukocytes in children with malaria: diagnostic value and association with disease severity. Malar. J. 2008, 7:109.
20. Kremsner P.G., et al. Prognostic value of circulating pigmented cells in African children with malaria. J. Infect. Dis. 2009, 199:142-150.
21. Hänscheid T., et al. Is flow cytometry better in counting malaria pigment-containing leukocytes compared to microscopy?. Malar. J. 2009, 8:255.
22. Awandare G., et al. Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia. Infect. Immun. 2007, 75:201-210.
23. Were T., et al. Naturally acquired hemozoin by monocytes promotes suppression of RANTES in children with malarial anemia through an IL-10-dependent mechanism. Microbes Infect. 2009, 11:811-819.
24. Davenport G.C., et al. Hematological predictors of increased severe anemia in Kenyan children coinfected with Plasmodium falciparum and HIV-1. Am. J. Hematol. 2010, 85:227-233.
25. Deroost K., et al. Hemozoin induces lung inflammation and correlates with malaria-associated acute respiratory distress syndrome. Am. J. Respir. Cell Mol. Biol. 2013, 48:589-600.
26. Coban C., et al. The malarial metabolite hemozoin and its potential use as a vaccine adjuvant. Allergol. Int. 2010, 59:115-124.
27. Hawkes M., et al. Malaria exacerbates experimental mycobacterial infection in vitro and in vivo. Microb. Infect. 2010, 12:864-874.
28. Schwarzer E., et al. Impairment of macrophage functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment. J. Exp. Med. 1992, 176:1033-1041.
29. Fiori P.L., et al. Reduced microbicidal and anti-tumour activities of human monocytes after ingestion of Plasmodium falciparum-infected red blood cells. Parasite Immunol. 1993, 15:647-655.
30. Sherry B.A., et al. Malaria-specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP-1α, and MIP-1β) in vitro, and altered thermoregulation in vivo. J. Inflamm. 1995, 45:85-96.
31. Coban C., et al. Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9. Cell Host Microbe 2010, 7:50-61.
32. Schwarzer E., et al. Malaria-parasitized erythrocytes and hemozoin nonenzymatically generate large amounts of hydroxy fatty acids that inhibit monocyte functions. Blood 2003, 101:722-728.
33. Frita R., et al. Simple flow cytometric detection of haemozoin containing leukocytes and erythrocytes for research on diagnosis, immunology and drug sensitivity testing. Malar. J. 2011, 10:74.
34. Shio M.T., et al. Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog. 2009, 5:e1000559.
35. Prato M., et al. Phagocytosis of hemozoin enhances matrix metalloproteinase-9 activity and TNF-α production in human monocytes: role of matrix metalloproteinases in the pathogenesis of falciparum malaria. J. Immunol. 2005, 175:6436-6442.
36. Coban C., et al. Manipulation of host innate immune responses by the malaria parasite. Trends Microbiol. 2007, 15:271-278.
37. Chen M.M., et al. Haemoproteus and Schistosoma synthesize heme polymers similar to Plasmodium hemozoin and β-hematin. Mol. Biochem. Parasitol. 2001, 113:1-8.
38. Pagola S., et al. The structure of malaria pigment β-haematin. Nature 2000, 404:307-310.
39. Schwarzer E., Arese P. Phagocytosis of malarial pigment hemozoin inhibits NADPH-oxidase activity in human monocyte-derived macrophages. Biochim. Biophys. Acta 1996, 1316:169-175.
40. Schwarzer E., et al. Phagocytosis of the malarial pigment, hemozoin, impairs expression of major histocompatibility complex class II antigen, CD54, and CD11c in human monocytes. Infect. Immun. 1998, 66:1601-1606.
41. Schwarzer E., et al. A luminescence method for the quantitative determination of phagocytosis of erythrocytes, of malaria-parasitized erythrocytes and of malarial pigment. Br. J. Haematol. 1994, 88:740-745.
42. Jaramillo M., et al. Synthetic Plasmodium-like hemozoin activates the immune response: a morphology-function study. PLoS ONE 2009, 4:e6957.
43. Coban C., et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 2005, 201:19-25.
44. Thomas V., et al. A novel way to grow hemozoin-like crystals in vitro and its use to screen for hemozoin inhibiting antimalarial compounds. PLoS ONE 2012, 7:e41006.
45. Skorokhod O., et al. Malarial pigment haemozoin, IFN-γ, TNF-α, IL-1β and LPS do not stimulate expression of inducible nitric oxide synthase and production of nitric oxide in immuno-purified human monocytes. Malar. J. 2007, 6:73.
46. Polimeni M., et al. Haemozoin induces early cytokine-mediated lysozyme release from human monocytes through p38 MAPK- and NF-κB-dependent mechanisms. PLoS ONE 2012, 7:e39497.
47. Coban C., et al. Purified malaria pigment (hemozoin) enhances dendritic cell maturation and modulates the isotype of antibodies induced by a DNA vaccine. Infect. Immun. 2002, 70:3939-3943.
48. Barrera V., et al. Host fibrinogen stably bound to hemozoin rapidly activates monocytes via TLR-4 and CD11b/CD18-integrin: a new paradigm of hemozoin action. Blood 2011, 117:5674-5682.
49. Parroche P., et al. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:1919-1924.
50. Jaramillo M., et al. Hemozoin increases IFN-γ-inducible macrophage nitric oxide generation through extracellular signal-regulated kinase-and NF-κB-dependent pathways. J. Immunol. 2003, 171:4243-4253.
51. Perkins D.J., et al. Severe malarial anemia: innate immunity and pathogenesis. Int. J. Biol. Sci. 2011, 7:1427-1442.
52. Carney C.K., et al. The basis of the immunomodulatory activity of malaria pigment (hemozoin). J. Biol. Inorg. Chem. 2006, 11:917-929.
53. Scorza T., et al. Hemozoin is a key factor in the induction of malaria-associated immunosuppression. Parasite Immunol. 1999, 21:545-554.
54. Millington O.R., et al. Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function. J. Biol. 2006, 5:5.
55. Urban B.C., Todryk S. Malaria pigment paralyzes dendritic cells. J. Biol. 2006, 5:4.
56. Dasari P., et al. Digestive vacuoles of Plasmodium falciparum are selectively phagocytosed by and impair killing function of polymorphonuclear leukocytes. Blood 2011, 118:4946-4956.
57. Dasari P., Bhakdi S. Pathogenesis of malaria revisited. Med. Microbiol. Immunol. 2012, 201:599-604.
58. Hänscheid T., et al. The issue if the phagocytosis of digestive vacuoles or hemozoin causes immune suppression may be more complex than presented in reply to Dasari, P. et al. Blood 2011, 118:4946-4956.
59. Schwarzer E., et al. Hemozoin stability and dormant induction of heme oxygenase in hemozoin-fed human monocytes. Mol. Biochem. Parasitol. 1999, 100:61-72.
60. Meckel H. About black pigment in spleen and blood of an insane woman. Zeitschr. Psychiatr. 1847, IV:198-216.
61. Day N.P., et al. Clearance kinetics of parasites and pigment-containing leukocytes in severe malaria. Blood 1996, 88:4694-4700.
62. Giribaldi G., et al. Involvement of inflammatory chemokines in survival of human monocytes fed with malarial pigment. Infect. Immun. 2010, 78:4912-4921.
63. Levesque M.A., et al. Splenic and hepatic hemozoin in mice after malaria parasite clearance. J. Parasitol. 1999, 85:570-573.
64. Frita R., et al. In vivo hemozoin kinetics after clearance of Plasmodium berghei infection in mice. Malar. Res. Treat. 2012, 2012:373086.
65. Schwarzer E., et al. Phagocytosis of malarial pigment haemozoin by human monocytes: a confocal microscopy study. Parasitology 2001, 123:125-131.
66. Sheel M., Engwerda C.R. The diverse roles of monocytes in inflammation caused by protozoan parasitic diseases. Trends Parasitol. 2012, 28:408-416.
67. Shapiro H., et al. Cytometry in Malaria - a practical replacement for microscopy?. Curr. Protoc. Cytom. 2013, 65. 11.20.1-11.20.23.